SCHEMBL7698574

SCHEMBL7698574

COc1ccc(COc2cc(NC(=O)O)c([N+](=O)[O-])cc2I)cc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.49
RAB9A P51151 7/20 0.49
SMN1; SMN2 Q16637 7/20 0.49
MAPK1 P28482 3/20 0.49
CYP19A1 P11511 1/20 0.47
MAPT P10636 6/20 0.47
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
HPGD P15428 1/20 0.45
ABCB1 P08183 1/20 0.43
ABCC1 P33527 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7138027 0.87 SMN1; SMN2 (0.44) NPC1RAB9ASMN1; SMN2MAPK1CYP19A1
SCHEMBL7700537 0.82 MAPT (0.46) NPC1RAB9ASMN1; SMN2MAPK1MAPT
SCHEMBL7137992 0.79 CYP19A1 (0.47) NPC1RAB9ASMN1; SMN2CYP19A1MAPT
SCHEMBL7704609 0.76 KDM4E (0.43) NPC1RAB9ASMN1; SMN2MAPK1MAPT
SCHEMBL15670979 0.75 CTSV (0.50) NPC1RAB9ASMN1; SMN2CYP19A1MAPT
SCHEMBL15670977 0.75 CTSV (0.50) NPC1RAB9ASMN1; SMN2CYP19A1MAPT
SCHEMBL978809 0.74 RAB9A (0.73) NPC1RAB9ASMN1; SMN2MAPK1MAPT
SCHEMBL3496332 0.74 SMN1; SMN2 (0.66) NPC1RAB9ASMN1; SMN2MAPK1MAPT
SCHEMBL978808 0.74 RAB9A (0.73) NPC1RAB9ASMN1; SMN2MAPK1MAPT
SCHEMBL3496338 0.74 SMN1; SMN2 (0.66) NPC1RAB9ASMN1; SMN2MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed